Hippo pathway signaling and YAP/TAZ
Hippo pathway signaling and YAP/TAZ is a research topic within Cell Biology. Science Explorer counts 14k research works in it since 1952. 10.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the role of the Hippo signaling pathway, particularly the involvement of YAP/TAZ, in mechanotransduction, cell proliferation, tissue growth control, organ size control, and its implications in cancer and stem cell regulation.
- Hippo Pathway
- YAP/TAZ
- mechanotransduction
- cell proliferation
- tissue growth control
- organ size control
- cancer
- regulation
- mechanobiology
- stem cells
- Research works
- 14k fractional, since 1952
- In the world top 10%
- 1.4k per year above
- Top-10% rate
- 10.1% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- -4% the tick is no change
- Largest producer
China
48% of the 10 largest, 2022-now
Which countries lead Hippo pathway signaling and YAP/TAZ research?
By volume, China and the United States publish the most (1.5k and 773 works in 2022-now).
By volume, 2022-now
- 1
China 1.5k works
- 2
United States 773 works
- 3
Japan 145 works
- 4
South Korea 112 works
- 5
Germany 106 works
- 6
United Kingdom 102 works
- 7
France 90 works
- 8
India 78 works
- 9
Canada 77 works
- 10
Italy 60 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Hippo pathway signaling and YAP/TAZ research?
By volume in 2022-now, Sun Yat-sen University publishes the most Hippo pathway signaling and YAP/TAZ research, followed by Shanghai Jiao Tong University and Sichuan University.
By volume, 2022-now
- 1
Sun Yat-sen University
China 47 works
- 2
Shanghai Jiao Tong University
China 46 works
- 3
Sichuan University
China 36 works
- 4
Zhejiang University
China 33 works
- 5
Fudan University
China 31 works
- 6
Harvard University
United States 30 works
- 7
Central South University
China 28 works
- 8
Nanjing Medical University
China 27 works
- 9
Chinese Academy of Sciences
China 24 works
- 10
Centre National de la Recherche Scientifique
France 23 works
Who are the leading researchers in Hippo pathway signaling and YAP/TAZ?
The most-cited researchers publishing on Hippo pathway signaling and YAP/TAZ include Peer Bork, Guido Kroemer and Bert Vogelstein.
- 1
Peer Bork
Germany 396k citations
- 2
Guido Kroemer
France 386k citations
- 3
Bert Vogelstein
United States 373k citations
- 4
Gad A. Getz
United States 364k citations
- 5
Elaine R. Mardis
United States 346k citations
- 6
Jun Wang
China 340k citations
- 7
Matthias Mann
Germany 308k citations
- 8
Robert A. Weinberg
United States 301k citations
- 9
Todd R. Golub
United States 283k citations
- 10
Matthew M. Meyerson
United States 280k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Hippo pathway signaling and YAP/TAZ research done?
The largest centres of Hippo pathway signaling and YAP/TAZ research in 2022-now are Shanghai (China), Beijing (China), Guangzhou (China) and Hangzhou (China).
Where is the best place to study Hippo pathway signaling and YAP/TAZ?
Among universities, judged by research, Sun Yat-sen University, Shanghai Jiao Tong University and Harvard University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Hippo pathway signaling and YAP/TAZ, country by countryIs Hippo pathway signaling and YAP/TAZ research growing?
Output in 2022-2025 was 4% lower than in 2018-2021, peaking in 2020.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Hippo pathway signaling and YAP/TAZ as a percentage of every work published that year, 0.013% in 2024.
Fractional works of Hippo pathway signaling and YAP/TAZ over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Hippo pathway signaling and YAP/TAZ. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.